BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29488412)

  • 1. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of
    Cuffaro B; Assohoun ALW; Boutillier D; Súkeníková L; Desramaut J; Boudebbouze S; Salomé-Desnoulez S; Hrdý J; Waligora-Dupriet AJ; Maguin E; Grangette C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32947881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.
    Rong J; Zheng H; Liu M; Hu X; Wang T; Zhang X; Jin F; Wang L
    BMC Microbiol; 2015 Oct; 15():196. PubMed ID: 26428623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Consortia and Their Metabolites Ameliorate the Symptoms of Inflammatory Bowel Diseases in a Colitis Mouse Model.
    Xu L; Liu B; Huang L; Li Z; Cheng Y; Tian Y; Pan G; Li H; Xu Y; Wu W; Cui Z; Xie L
    Microbiol Spectr; 2022 Aug; 10(4):e0065722. PubMed ID: 35730951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.
    Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I
    PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
    Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
    Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
    Torres-Maravilla E; Carvalho FA; Holowacz S; Delannoy J; Lenoir L; Jacouton E; Barbut F; Langella P; Bermúdez-Humarán LG; Waligora-Dupriet AJ
    Benef Microbes; 2024 Apr; 15(3):293-310. PubMed ID: 38677716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice.
    Holowacz S; Blondeau C; Guinobert I; Guilbot A; Hidalgo S; Bisson JF
    Benef Microbes; 2018 Feb; 9(2):299-309. PubMed ID: 29409331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy: A Novel Mechanism Involved in the Anti-Inflammatory Abilities of Probiotics.
    Zaylaa M; Alard J; Kassaa IA; Peucelle V; Boutillier D; Desramaut J; Rosenstiel P; Nguyen HTT; Dabboussi F; Pot B; Grangette C
    Cell Physiol Biochem; 2019; 53(5):774-793. PubMed ID: 31647207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.
    Elian SD; Souza EL; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS
    Benef Microbes; 2015; 6(3):277-86. PubMed ID: 25391346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect.
    Presti I; D'Orazio G; Labra M; La Ferla B; Mezzasalma V; Bizzaro G; Giardina S; Michelotti A; Tursi F; Vassallo M; Di Gennaro P
    Appl Microbiol Biotechnol; 2015 Jul; 99(13):5613-26. PubMed ID: 25744647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model.
    Daniel C; Poiret S; Goudercourt D; Dennin V; Leyer G; Pot B
    Appl Environ Microbiol; 2006 Sep; 72(9):5799-805. PubMed ID: 16957197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.
    Foligné B; Nutten S; Steidler L; Dennin V; Goudercourt D; Mercenier A; Pot B
    Dig Dis Sci; 2006 Feb; 51(2):390-400. PubMed ID: 16534687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: Reverse engineering development of an anti-inflammatory cheese.
    Plé C; Breton J; Richoux R; Nurdin M; Deutsch SM; Falentin H; Hervé C; Chuat V; Lemée R; Maguin E; Jan G; Van de Guchte M; Foligné B
    Mol Nutr Food Res; 2016 Apr; 60(4):935-48. PubMed ID: 26640113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease.
    Feighery LM; Smith P; O'Mahony L; Fallon PG; Brayden DJ
    Dig Dis Sci; 2008 Sep; 53(9):2495-506. PubMed ID: 18157694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological Characteristics of
    Liu Y; Li Y; Yu X; Yu L; Tian F; Zhao J; Zhang H; Zhai Q; Chen W
    J Microbiol Biotechnol; 2021 Jan; 31(1):92-103. PubMed ID: 32522964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.